Principal Investigator Shiladitya Sengupta
We approach nanotechnology as a tool to solve problems in medicine. We use the understanding of a disease to design hybrid nanotechnology platforms. We are currently working on a new concept, a 'nanocell' that enables the spatiotemporal therapy against complex diseases such as cancer.